Bone Marrow Biopsy Operator Experience and Impact on Aspirate, Biopsy, and Ancillary Testing Quality
| Autor: | David E. Ruffridge, Matthew T. Howard, Hong Fang, Richard J. Allen, Rebecca L. King, Edward A. Eick, Joseph J. Haack, Lisa M. Marinelli, Colleen M. Byrne, Curtis A. Hanson |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
0301 basic medicine
medicine.medical_specialty lcsh:R5-920 medicine.diagnostic_test business.industry Ancillary Study 03 medical and health sciences 030104 developmental biology 0302 clinical medicine medicine.anatomical_structure Specimen Quality BM - Bone marrow 030220 oncology & carcinogenesis Biopsy medicine Radiology Bone marrow business lcsh:Medicine (General) |
| Zdroj: | Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 2, Iss 3, Pp 241-247 (2018) |
| ISSN: | 2542-4548 |
| Popis: | Objective: To assess the relationship between bone marrow (BM) biopsy operator experience and both specimen quality and ancillary testing utilization. Patients and Methods: We evaluated all referred and in-house (IH) BM biopsy specimens obtained over a contiguous 6-week period from April 3, 2017, to May 19, 2017. The BM specimens were assessed for the length of interpretable marrow, and aspirates were assessed for the presence of spicules. Subgroup comparisons included IH BM obtained by a trained team of nurses within our institution, patients clinically referred (CR) to our institution with outside-obtained BM specimens, and outside pathologist-referred (PR) consultation cases. Ancillary study usage was compared between the first 100 cases of each group. Results: A total of 1191 BM specimens were analyzed, including 600 IH, 288 CR, and 303 PR cases with biopsies and/or aspirates. The average interpretable biopsy lengths of IH, CR, and PR cases were 16.0 mm, 10.0 mm, and 7.0 mm, respectively (P |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|